Journal of Clinical & Experimental OncologyISSN: 2324-9110

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Garbajs M Author

peter.popovic@kclj.si

Subjects of specialization
Mucoepidermoid carcinoma, Cancer chemotherapy, Prostate biomarker, Endometrial cancer, Tumor marker

Affiliation
Clinical Institute of Radiology, University Medical Centre, Ljubljana, Slovenia

Biography

Garbajs M was working in the Clinical Institute of Radiology, University Medical Centre, Ljubljana, Slovenia. Doctor has more than 40 publications. Doctor's current research area related to clinical oncology.

Publications

Research Article Open Access

Prognostic Factors for Survival in Patients with Hepatocellular Carcinoma Treated By Transarterial Chemoembolization Using Drug-Eluting Beads

Author(s):

Levasicc N, Lesnik LA, Garbajs M, Dezman R and Popovic P

Objective: Transarterial chemoembolization (TACE) is the most widely used therapeutic option in the treatment of intermediate hepatocellular carcinoma (HCC). Due to the heterogeneity of the intermediate stage patient population, survival rates are variable. The purpose of this retrospective study was to investigate prognostic factors in predicting overall survival in patients with HCC treated by transarterial chemoembolization using drug-eluting beads loaded with doxorubicin (DEBDOX TACE).

Methods: 119 patients with intermediate stage HCC who had undergone DEBDOX TACE between February 2010 and January 2017 were studied. All procedures were performed under Cone Beam Computed Tomography (CBCT) control. Survival was calculated from the date of the ... view more»

DOI: 10.4172/2324-9110.1000230

Abstract HTML PDF

Google Scholars / Researchers Sites

Explore SciTechnol

GET THE APP